CLYM compared with SION: revenue, margins and what each company keeps, and the suppliers and customers both name

CLYMClimb Bio, Inc.

Mkt capRevenueRevenue

SIONSionna Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CLYMClimb Bio, Inc.

SIONSionna Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CLYM1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±40.4%▲+12.27%×0.30

SION

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+4.80%—

May 12 '26±10.9%▼−10.90%×1.00

= impliedCLYM realized, solidSION realized, hatchedOne scale, both sides: full bar = 41%× = |realized| ÷ impliedSource: market data

Q1 FY26

—

▼−7.17%

—

Nov 5 '25—▼−1.57%—

CLYMClimb Bio, Inc.

9.64▼−1.07%

Mkt cap$559.4M

SIONSionna Therapeutics, Inc.

3.70▼−0.69%

Regular sessionNov 3 '26

Mkt cap$168.4M

Compare

Regular sessionNov 3 '26

CLYMClimb Bio, Inc.

SIONSionna Therapeutics, Inc.

9.64▼−1.07%

Price

3.70▼−0.69%

$559.4M

Mkt cap

$168.4M

CLYM9.64▼−1.07%vsSION3.70▼−0.69%Regular sessionNov 3 '26